Close
Show
Home Clinical Trials

Clinical Trials

World Pharma Today clinical Trials covers all updates & latest in clinical trials news, Pharma clinical trial company news, clinical trials technology…

Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formulation to treat Covid-19

Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formulation to treat...


Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1...
Humanigen Reports Positive Phase 3 Topline Results Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19

Humanigen Reports Positive Phase 3 Topline Results Improves Survival Without Need for Mechanical Ventilation...


Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called...
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

Foresee Pharma Announces Dosing of First Patient in Phase 2/3 Clinical Trial of FP-025...


Foresee Pharmaceuticals Co., Ltd. announced the initiation of patient dosing in the Phase 2/3 clinical...
NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI in the I-SPY COVID-19 Trial

Lilly, Vir And GSK Report Positive Topline Data From COVID-19 Trial Of Bamlanivimab With...


Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced topline data from the...
CyanVac Selects Exothera for the Development and GMP Mfg anufacturing of its COVID-19 Intranasal Vaccine Candidate for Phase III Clinical Trial is Europe and the US

CyanVac Selects Exothera for the Development and GMP Mfg anufacturing of its COVID-19 Intranasal...


CyanVac LLC, a vaccine company, announced that they have selected Exothera S.A., a full-service Contract...
Regeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA EUA

Phase 3 Trial Shows REGEN-COV antibody Cocktail Reduced Hospitalization or Death by 70% in...


Regeneron Pharmaceuticals, Inc. announced positive topline results from the largest trial to date assessing a...
Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists

BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging


BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe...
Accenture and Phesi urges pharmaceutical companies to make use of synthetic data in clinical trials

Accenture and Phesi urges pharmaceutical companies to make use of synthetic data in clinical...


Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, and Accenture,...
CureVacs COVID-19 Vaccine Candidate, CVnCoV, Suitable for Standard Fridge Temperature Logistics

CureVac Expands CVnCoV COVID-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant...


CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on...
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

Moderna starts Phase I study of new Covid-19 vaccine candidate


Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the...